Contact
Please use this form to send email to PR contact of this press release:
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
TO: